Despre acest podcast
Touching Base is the dynamic podcast series from the editors of GEN (Genetic Engineering & Biotechnology News). Each episode features a rotating cast of senior editors including John Sterling, Kevin Davies, Julianna LeMieux, Alex Philippidis, Uduak Thomas, Corinna Singleman and Fay Lin who delve into emerging stories, exchange ideas, and debate the latest trends in biotech. Additionally, they talk to some of the leading voices in the industry about what's now and next. Hosted on Acast. See acast.com/privacy for more information.
Episoade
Cele mai noi 20 din 56 episoade
- BMS’s New Facility, Recursion–Genentech Partnership, Long-COVID and Persistent C.auris · 38 min · Episodul 56Bristol Myers Squibb has selected Houston as the site for a new $2.3 billion multi-modal manufacturing campus designed to support drug product and finished goods manufacturing…
- Axiom’s Hong Kong Bet, Latigo’s Positive Phase II, and Base Editors for Huntington’s · 32 min · Episodul 55In the business news section of this week’s episode, Axiom Biosciences recently announced its plans to go public and made headlines for its plans to do so on the Hong Kong…
- Parkinson’s in the Clinic, Insilico enters Phase III, Vertex Acquires Crinetics · 32 min · Episodul 54Promise hits Parkinson’s disease therapy, as a Phase I/II clinical study has demonstrated the feasibility of transplanting stem-cell-derived dopamine progenitor cells into the…
- Merck and Insilico Make Deals, Claude Science’s Debut, Vaccines for Neglected Diseases · 36 min · Episodul 53More big biotech deals on the docket this week. First, Merck KGaA is buying Bio-Techne for $11.3 billion to expand its presence in high-growth life science markets. We dive into…
- Historic Biotech IPO, Merck, Protillion’s AI Deal, Testing a Lassa–Rabies Vaccine · 35 min · Episodul 52We are still talking about big pharma deals and biotech fundraising in this episode. The big news this week was Parabilis Medicines’s history-making IPO. We dive into the drug…
- A Billion-Dollar Deal, Trial Trouble, Biohub Updates, and Vaccine Research News · 37 min · Episodul 51In this week’s episode, we start with news that Fulcrum Therapeutics is scrapping its lead pipeline program for sickle cell disease following concerns from the FDA about the…
- AI Scientists, Stock Tumble, Patent Lawsuit, and New Partnerships · 32 min · Episodul 50Agentic AI is growing in its applications. Google DeepMind and Edison are leveraging the growing capabilities by developing AI Scientists. These platforms are poised to…
- Remembering J. Craig Venter, PhD · 44 min · Episodul 49Craig Venter recently passed away at the age of 79 from complications following a cancer diagnosis. He was well known in both science and industry and was an integral part of…
- AI in Oncology Takes Off, Tackling HIV and Liver Disease, Pharma’s Recent Gains · 33 min · Episodul 48Some GEN editors were in sunny San Diego covering the hottest research, trends, and products from the American Association for Cancer Research meeting. We kick things off with…
- Drugs from a Text Prompt, Wegovy Pill Competition Dampens Lilly’s Surge · 32 min · Episodul 47From designing drugs with a simple text prompt to running experiments guided by extended reality, a new wave of agentic AI is transforming the modern lab. Our editors discuss the…
- Agentic AI, Virtual Cell, LNP Vaccine Boosters, Engineered Organs, and Mergers · 40 min · Episodul 46This week, agentic AI steps into the limelight buoyed by the momentum from generative AI. And there’s a new virtual cell model in town courtesy of AI-drug developer Xaira…
- Bacteria 4D Simulation, Safer Large Gene Insertion, uniQure Roller Coaster · 41 min · Episodul 45A new study from the J. Craig Venter Institute simulates the complete life cycle of a minimal bacterial cell in 4D space and time at nanoscale resolution. Meanwhile, in gene…
- AI for Scientists, FDA Reverses Course, and Advances in Cancer Therapeutics · 39 min · Episodul 44In the industry news section of this week’s episode, we kick things off with Tamarind Bio’s efforts to develop user-friendly artificial intelligence tools for science…
- Women in Science, Robotics, Automation, SLAS, and Lilly Updates · 33 min · Episodul 43Women in Science Day (February 11) was the top of the list for discussion for GEN editors in this week’s podcast. They shared an anecdote on the history of the term…
- Ex-CEO Behind Bars, 10x’s Clinical Ambitions, and Pharma’s AI Gambit · 34 min · Episodul 42We kick off the very first episode of 2026 with a major legal development. This week, the former CEO of CytoDyn was sentenced to 30 months in prison, more than a year after being…
- Editors’ Choice: Top Stories of 2025 · 41 min · Episodul 41In the final episode of 2025, the GEN team came together to reflect on some of the stories over the last year that they each found impactful. Some of the stories were covered in…
- Lung Organoids, Autism and Sarcopenia Insights in Mice, and a Bidding War Ends · 36 min · Episodul 40Stories on lung organoids and autism were some of the most read this week. We kicked things off by digging into recent breakthroughs in both areas including an automated method…
- New Nasal Vaccines, Korro Stock Dips, J&J and Merck Acquisitions, and Dyno GATC · 42 min · Episodul 39Nasal vaccines show new promise for human papillomavirus (HPV) to address cervical cancer and whooping cough. In business news, Korro's stock craters 81% as AATD interim Phase…
- uniQure Staggers at FDA, Recursion's Microglia Map, and Leadership Transitions · 32 min · Episodul 38uniQure's “game changing” data announced in September, which showed significant slowing of Huntington’s disease (HD) progression in patients treated with its gene therapy…
- Artificial Intelligence in the Emerald City and Targeting Colon Cancer Stem Cells · 24 min · Episodul 37We are gearing up for our annual AI in Drug Discovery summit in a few days. So, for this episode, we focused on some recent AI news coverage. First, GEN senior editor Fay Lin…
